IL57670A - Phenethanolamines,their preparation and pharmaceutical formulations comprising them - Google Patents

Phenethanolamines,their preparation and pharmaceutical formulations comprising them

Info

Publication number
IL57670A
IL57670A IL57670A IL5767079A IL57670A IL 57670 A IL57670 A IL 57670A IL 57670 A IL57670 A IL 57670A IL 5767079 A IL5767079 A IL 5767079A IL 57670 A IL57670 A IL 57670A
Authority
IL
Israel
Prior art keywords
phenethanolamines
preparation
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
IL57670A
Other languages
English (en)
Other versions
IL57670A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL57670A0 publication Critical patent/IL57670A0/xx
Publication of IL57670A publication Critical patent/IL57670A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL57670A 1978-07-03 1979-06-26 Phenethanolamines,their preparation and pharmaceutical formulations comprising them IL57670A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92166878A 1978-07-03 1978-07-03

Publications (2)

Publication Number Publication Date
IL57670A0 IL57670A0 (en) 1979-10-31
IL57670A true IL57670A (en) 1982-11-30

Family

ID=25445786

Family Applications (1)

Application Number Title Priority Date Filing Date
IL57670A IL57670A (en) 1978-07-03 1979-06-26 Phenethanolamines,their preparation and pharmaceutical formulations comprising them

Country Status (33)

Country Link
EP (2) EP0047536B1 (nl)
JP (1) JPS559100A (nl)
AR (2) AR222658A1 (nl)
AT (1) AT370408B (nl)
AU (1) AU521744B2 (nl)
BE (1) BE877392A (nl)
BG (3) BG40482A3 (nl)
CA (1) CA1120058A (nl)
CH (1) CH641759A5 (nl)
CS (2) CS208660B2 (nl)
DD (1) DD144763A5 (nl)
DK (1) DK268579A (nl)
EG (1) EG14400A (nl)
ES (2) ES482153A1 (nl)
FI (1) FI67686C (nl)
FR (1) FR2430409A1 (nl)
GB (1) GB2028800B (nl)
GR (1) GR72546B (nl)
HK (1) HK44087A (nl)
HU (1) HU179170B (nl)
IE (1) IE48436B1 (nl)
IL (1) IL57670A (nl)
LU (1) LU81456A1 (nl)
MX (1) MX6160E (nl)
MY (1) MY8500596A (nl)
NZ (1) NZ190859A (nl)
PH (1) PH15650A (nl)
PL (2) PL123990B1 (nl)
PT (1) PT69840A (nl)
RO (2) RO83053B (nl)
SU (2) SU965351A3 (nl)
YU (1) YU154879A (nl)
ZA (1) ZA793295B (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0102213A1 (en) * 1982-08-21 1984-03-07 Beecham Group Plc Ethanolamine derivatives, pharmaceutical compositions containing them, and processes for preparing them
PL144053B1 (en) * 1983-01-31 1988-04-30 Lilly Co Eli Method of stimulating growth of domesticated animals,improving effectivness of food utilization ba domesticated animals and improving leanness of domesticated animals and fodder pre-mixture
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
JPS62155213A (ja) * 1985-12-20 1987-07-10 イ−ライ・リリ−・アンド・カンパニ− 腫瘍細胞崩壊剤
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β-拟肾上腺素兴奋剂型饲料添加剂的合成方法
US7547716B2 (en) 2001-06-08 2009-06-16 Institute Of Medicinal Molecular Design, Inc. Sulfonamide derivatives
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6610530A (nl) * 1966-07-27 1968-01-29
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts

Also Published As

Publication number Publication date
AR222658A1 (es) 1981-06-15
SU931102A3 (ru) 1982-05-23
IE791231L (en) 1980-01-03
EP0007206A1 (en) 1980-01-23
FR2430409B1 (nl) 1981-05-29
MY8500596A (en) 1985-12-31
ATA463979A (de) 1982-08-15
NZ190859A (en) 1984-09-28
CS208660B2 (en) 1981-09-15
LU81456A1 (fr) 1979-10-30
SU965351A3 (ru) 1982-10-07
ES8101537A1 (es) 1980-12-16
GR72546B (nl) 1983-11-17
IE48436B1 (en) 1985-01-23
FI67686C (fi) 1985-05-10
AR222727A1 (es) 1981-06-15
HU179170B (en) 1982-08-28
RO83053A (ro) 1984-02-21
EG14400A (en) 1983-12-31
GB2028800A (en) 1980-03-12
PL123990B1 (en) 1982-12-31
BG40480A3 (en) 1986-12-15
BG40482A3 (en) 1986-12-15
EP0047536A2 (en) 1982-03-17
FI792080A (fi) 1980-01-04
PH15650A (en) 1983-03-11
DK268579A (da) 1980-01-04
BG40481A3 (en) 1986-12-15
JPS636058B2 (nl) 1988-02-08
RO77731A (ro) 1981-11-24
FR2430409A1 (fr) 1980-02-01
BE877392A (fr) 1980-01-02
GB2028800B (en) 1982-11-03
ES482153A1 (es) 1980-08-16
EP0007206B1 (en) 1983-02-23
EP0047536A3 (en) 1982-03-24
AU4848879A (en) 1980-01-10
AU521744B2 (en) 1982-04-29
YU154879A (en) 1983-04-30
CA1120058A (en) 1982-03-16
EP0047536B1 (en) 1984-06-27
RO83053B (ro) 1984-02-28
DD144763A5 (de) 1980-11-05
MX6160E (es) 1984-11-29
FI67686B (fi) 1985-01-31
AT370408B (de) 1983-03-25
PL119783B1 (en) 1982-01-30
HK44087A (en) 1987-06-12
PL222867A1 (nl) 1981-01-02
PL216810A1 (nl) 1980-07-28
ZA793295B (en) 1981-02-25
ES487847A0 (es) 1980-12-16
PT69840A (en) 1979-07-01
CS208661B2 (en) 1981-09-15
JPS559100A (en) 1980-01-22
CH641759A5 (fr) 1984-03-15
IL57670A0 (en) 1979-10-31

Similar Documents

Publication Publication Date Title
DE2964091D1 (en) Phenethanolamines, their formulations, use and preparation
CY1250A (en) N-heterocyclyl-4-piperdinamines,methods for their preparation and pharmaceutical compositions comprising them
DE2963797D1 (en) Amino-dibenzopyrans, their preparation, formulations containing them and their use as pharmaceuticals
IL57670A (en) Phenethanolamines,their preparation and pharmaceutical formulations comprising them
IL56612A (en) 1-aryloxy-3-nitratoalkylamino-2-propanols,process for their preparation,and pharmaceutical compositions comprising them
IL60918A0 (en) 6-pyridayinones,their preparation and pharmaceutical compositions cosntaining them
IL59558A (en) 9-aminoalkylfluorenes,their preparation and pharmaceutical compositions comprising them
IL57599A0 (en) Indolealkylamines,pharmaceutical formulations containing these and processes for their preparation
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
DE3062268D1 (en) Alkoxybenzylpyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
DE2966364D1 (en) Phenyl-alkanoic acid derivatives, the preparation thereof and pharmaceutical compositions containing them
MY8500281A (en) Pharmaceutical and food formulations
ZA79395B (en) Pharmaceutical formulations
IL57802A (en) Thio-substituted benzoylpropionyl-l-prolines,their preparation and pharmaceutical compositions comprising them
ZA793131B (en) Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation
IL56686A0 (en) Acylaminoalkyl-syanoguanidines,their preparation and pharmaceutical compositions containing them
IL57891A (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
IL57754A0 (en) Benzopyranotriazoles,their preparation and pharmaceutical compositions containing them
IL57219A (en) 10-methoxy-daunorubicin,10-methoxy-doxorubicin,their derivatives,preparation thereof,and pharmaceutical compositions comprising them
IL57862A0 (en) 1-benzoyl-3-pyridinyl ureas,their use,preparation and formulations
IL56728A (en) Androstadienes,their preparation and pharmaceutical compositions containing them
IL57504A0 (en) Prostagandin analogues,their preparation and pharmaceutical compositions containing
EP0004529A3 (en) Arylaminoimidazoline derivatives, their preparation, their analgetic application and pharmaceutical formulations
HK12384A (en) Novel veratramides,their preparation and pharmaceutical compositions containing them
GB2024818B (en) Phenathrenederivatives, their preparation and pharmaceutical compositions containing them